Abstract
2561 Effects of concomitant use of abiraterone and/or enzalutamide with radium-223 on safety and overall survival in metastatic castration-resistant prostate cancer (mCRPC) patients treated in an international early access program (EAP)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have